Dr Michael Dunn
Head of Genetics and Molecular Sciences, Wellcome and Non-Voting Member of the Board of Management
Michael Dunn is the Wellcome representative on the Sanger Institute’s Board of Management.
Michael is responsible for developing, managing and overseeing an exciting and world-leading portfolio of research at Wellcome. Before taking on the role of Director of Discovery Research he led the management of Wellcome’s Genetics and Molecular Sciences portfolio.